ATAI Company Profile and Key Details

Atai Beckley N.V (NASDAQ:ATAI) closed at $4.30 USD, gaining $0.34 (8.59%) from the previous close of $3.96. The stock is currently mid-range between its 52-week high and low $1.15 and $6.75. With a market capitalization of about $811.09 million, Atai Beckley N.V is classified as a small-cap and shows higher-than-market volatility (beta ~1.62). Key stats such as the average daily volume over the past year has been around 5.65 million shares, in line with its 52-week average. Headquartered in Amstelveen, None, Atai Beckley N.V operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Srinivas G. Rao, the company employs approximately 54 people and listed since June 18, 2021. Atai Beckley NV is a clinical-stage biopharmaceutical company.

ATAI has shown mixed momentum, gaining 0.23% over the past week and -11.89% over the past quarter, though year-to-date performance is up 223.31%. Short-term trend indicators are mixed aligned (SMA20 4.61%, SMA50 -8.37%, SMA200 28.06%). The stock’s 14-day RSI is 51.24 (neutral), while the ATR of 0.26 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -36.3% below its high and over 273.91% above its low. Average 10-day trading volume of 3.49 million shares is below the 3-month average of 5.55 million, indicating normal recent market interest.

Atai Beckley N.V last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.05. This means the shares are trading below this model’s fair value.

Atai Beckley N.V has 363.21 million shares outstanding. The public float is 301.26 million shares, elevated short interest at 4.43% of float. This equals 13.64 million shares. The short ratio is 2.83 days. Institutional investors hold 43.13% of the float. Insiders own 7.7%. Apeiron Investment Group Ltd. holds 51.05 million shares, ATAI Life Sciences N.V. has 12.00 million shares and Auerbach Michael has 5.56 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Atai Beckley N.V generated EPS of -$0.80 over the past year. Five-year average earnings growth is 18.62%. Wall Street analysts project EPS growth of 23.25% annually over the next five years. The latest quarter delivered EPS of -$0.28. The next quarter is forecast at -$0.10. Next year's EPS is expected at -$131.78. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 10 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $15.00 to $10.00. The high target offers 248.84% upside. The low target suggests 132.56% downside. The mean target is $12.09. This offers 181.16% upside. Atai Beckley N.V earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 12, 2025, missed forecasts by 133.89%. The prior quarter beat by 16.67%. Over the last six quarters, Apple has recorded several small beats. These include 111.76% in August 13, 2024.

Atai Beckley N.V (NASDAQ:ATAI) shares are up 223.31% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Atai Beckley N.V trading at a premium to the broader market with a P/E of -6.02. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.09, suggesting 274.19% upside. Our AI forecast model points to short-term weakness (-2.09% over two weeks), a medium-term rise (126.51% over three months), and a longer-term gain (420.7% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Atai Beckley N.V stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.09%, with price expected at $4.21 by January 02, 2026, within a range of $3.92 to $4.52 3-Month Outlook: Projected rise of 126.51%, reaching $9.74 by March 19, 2026, with a range of $9.66 to $9.81. 1-Year Outlook: Projected gain of 420.7%, with price at $22.39 by December 18, 2026, within a range of $23.06 to $23.25.

Atai Beckley N.V trades at a P/E ratio of -6.02, slightly below the S&P 500 average, with a price-to-sales ratio of 266.56 and a price-to-book ratio of 5.81 trading at moderately above to book value. The P/FCF stands at -10.11, also below market averages.